Lotte Food Pasteur 'WithMom Jewang' Expanded Release for All Infant Ages

[Asia Economy Reporter Lim Hye-seon] Lotte Food Pasteur announced on the 28th that it will expand the release of 'Withmom C-section' to cover the entire age range up to 36 months after birth.

'Withmom C-section,' introduced by Pasteur, is a product with enhanced functionality tailored to the changing childbirth environment. According to data from the Health Insurance Review & Assessment Service and Statistics Korea, as of 2019, the rate of mothers delivering by cesarean section reached 50.5%, surpassing natural births for the first time. This rate continues to rise, indicating ongoing changes in the childbirth environment.

In this context, Withmom C-section, launched by Pasteur in September last year, has seen sales increase by more than 30% compared to existing products, and overall sales of Pasteur infant formula have grown by about 2-3% annually. This achievement comes amid a continuous decline in the overall infant formula market due to low birth rates.

According to the Korea Agro-Fisheries & Food Trade Corporation (aT) Food Industry Statistics Information, the infant formula market size, which reached 446 billion KRW in 2015, recorded 367 billion KRW last year, a decrease of 17.7%. It is expected to shrink further to 323 billion KRW by 2025.

Withmom C-section focuses on the fact that healthy intestines of naturally born newborns contain abundant Bifidobacterium longum (B.longum) probiotics. It is an infant food jointly developed by Lotte Food Pasteur, Lotte Central Research Institute, and leading domestic university hospitals. The Bifidobacterium longum (B.longum) applied in Withmom C-section was developed by the Rural Development Administration and holds multiple domestic patents and academic papers.

Additionally, it is designed as a synbiotic by combining four types of probiotics and three types of prebiotics that serve as food for probiotics, helping infants establish a healthy intestinal environment. It also applies ESP probiotic cell metabolites, which have a patent for rotavirus inhibition. Rotavirus is known to be a major cause of over 50% of severe diarrhea cases.

This content was produced with the assistance of AI translation services.